Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution

MLA

Arik Dahan, et al. “Lamotrigine Therapy in Patients after Bariatric Surgery: Potentially Hampered Solubility and Dissolution.” International Journal of Pharmaceutics, vol. 612, Jan. 2022, p. 121298. EBSCOhost, https://doi.org/10.1016/j.ijpharm.2021.121298.

APA

Arik Dahan, Julie Vaynshtein, Oleg Dukhno, Ella Vainer, Roni Gibori, Daniel Porat, Carmil Azran, & Yoni Mualem. (2022). Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution. International Journal of Pharmaceutics, 612, 121298. https://doi.org/10.1016/j.ijpharm.2021.121298

Chicago

Arik Dahan, Julie Vaynshtein, Oleg Dukhno, Ella Vainer, Roni Gibori, Daniel Porat, Carmil Azran, and Yoni Mualem. 2022. “Lamotrigine Therapy in Patients after Bariatric Surgery: Potentially Hampered Solubility and Dissolution.” International Journal of Pharmaceutics 612 (January): 121298. doi:10.1016/j.ijpharm.2021.121298.